CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-55 Cr | ₹-109 Cr | ₹-146 Cr | ₹129 Cr | ₹224 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CIPLA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-55 Cr |
Mar2023 | ₹-109 Cr |
Mar2022 | ₹-146 Cr |
Mar2021 | ₹129 Cr |
Mar2020 | ₹224 Cr |
How is Net Cash Inflow / Outflow of CIPLA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-55 Cr | Negative | |
Mar2023 | ₹-109 Cr | Negative | |
Mar2022 | ₹-146 Cr | Negative | |
Mar2021 | ₹129 Cr | -42.54 | |
Mar2020 | ₹224 Cr | - |
Compare Net Cash Inflow / Outflow of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹116,431.7 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
MANKIND PHARMA | ₹99,974.0 Cr | 2.1% | 3.7% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -5.4% |
-1.5% |
0.8% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses